Literature DB >> 11709323

Effects of lansoprazole and amoxicillin on uptake of [(14)C]clarithromycin into gastric tissue in rats.

H Endo1, H Yoshida, N Ohmi, S Higuchi.   

Abstract

Triple therapy consisting of clarithromycin (CLR), lansoprazole (LPZ), and amoxicillin (AMZ) is effective as eradication therapy for patients with peptic ulcer disease and Helicobacter pylori infection. We evaluated the effects of LPZ and AMZ on the uptake of [(14)C]CLR into the gastric tissue of rats. After administration of [(14)C]CLR alone or in combination with LPZ and AMZ, the distributions of [(14)C]CLR in the main organs and gastrointestinal tissues were compared. LPZ and AMZ had no effect on the distribution of [(14)C]CLR in any tissue except gastric tissue. The concentration of radioactivity in gastric tissue was several times higher when [(14)C]CLR was administered orally together with LPZ than when it was administered alone. The gastric emptying of [(14)C]CLR became smaller in the case of the coadministration of LPZ. AMZ had no apparent influence on the disposition of [(14)C]CLR. After the intravenous administration of [(14)C]CLR, no effects of drug coadministration were evident. In vitro uptake of [(14)C]CLR into gastric tissue was enhanced in the case of a high-pH environment. The uptake was not influenced by the concurrent presence of LPZ and AMZ. These results suggest that the penetration of [(14)C]CLR possibly depends on elevated gastric pH, as gastric acid secretion was inhibited by LPZ, and this may be a primary factor in explaining why the concentration of [(14)C]CLR at the target site, gastric tissue, was enhanced by the coadministration of LPZ.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11709323      PMCID: PMC90852          DOI: 10.1128/AAC.45.12.3451-3455.2001

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  18 in total

Review 1.  Helicobacter pylori and peptic ulcer disease.

Authors:  W L Peterson
Journal:  N Engl J Med       Date:  1991-04-11       Impact factor: 91.245

Review 2.  Review article: the treatment of Helicobacter pylori infection.

Authors:  R V Heatley
Journal:  Aliment Pharmacol Ther       Date:  1992-06       Impact factor: 8.171

3.  Unidentified curved bacilli on gastric epithelium in active chronic gastritis.

Authors:  J R Warren; B Marshall
Journal:  Lancet       Date:  1983-06-04       Impact factor: 79.321

4.  Dual therapy using a double dose of lansoprazole with amoxicillin versus triple therapy using a double dose of lansoprazole, amoxicillin, and clarithromycin to eradicate Helicobacter pylori infection: results of a prospective randomized open study.

Authors:  H Lamouliatte; R Cayla; F Zerbib; S Forestier; A de Mascarel; M Joubert-Collin; F Mégraud
Journal:  Am J Gastroenterol       Date:  1998-09       Impact factor: 10.864

5.  Antisecretory and antiulcer activities of a novel proton pump inhibitor AG-1749 in dogs and rats.

Authors:  H Satoh; N Inatomi; H Nagaya; I Inada; A Nohara; N Nakamura; Y Maki
Journal:  J Pharmacol Exp Ther       Date:  1989-02       Impact factor: 4.030

6.  Differences in the antisecretory actions of the proton pump inhibitor AG-1749 (lansoprazole) and the histamine H2-receptor antagonist famotidine in rats and dogs.

Authors:  H Nagaya; N Inatomi; H Satoh
Journal:  Jpn J Pharmacol       Date:  1991-04

7.  Physicochemical properties and stability in the acidic solution of a new macrolide antibiotic, clarithromycin, in comparison with erythromycin.

Authors:  Y Nakagawa; S Itai; T Yoshida; T Nagai
Journal:  Chem Pharm Bull (Tokyo)       Date:  1992-03       Impact factor: 1.645

8.  The efficacy of antimicrobial treatment in Campylobacter pylori-associated gastritis and duodenal ulcer.

Authors:  A M Hirschl; E Hentschel; K Schütze; H Nemec; R Pötzi; A Gangl; W Weiss; M Pletschette; G Stanek; M L Rotter
Journal:  Scand J Gastroenterol Suppl       Date:  1988

9.  Susceptibility of Campylobacter pylori to macrolides and fluoroquinolones.

Authors:  D J Hardy; C W Hanson; D M Hensey; J M Beyer; P B Fernandes
Journal:  J Antimicrob Chemother       Date:  1988-11       Impact factor: 5.790

10.  Comparative pharmacokinetics of clarithromycin (TE-031), a new macrolide antibiotic, and erythromycin in rats.

Authors:  Y Kohno; H Yoshida; T Suwa; T Suga
Journal:  Antimicrob Agents Chemother       Date:  1989-05       Impact factor: 5.191

View more
  2 in total

1.  Effect of sucralfate on antibiotic therapy for Helicobacter pylori infection in mice.

Authors:  Koichiro Watanabe; Kazunari Murakami; Ryugo Sato; Koji Kashimura; Masahiro Miura; Satoshi Ootsu; Hajime Miyajima; Masaru Nasu; Tadayoshi Okimoto; Masaaki Kodama; Toshio Fujioka
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

2.  Effects of clarithromycin and amoxicillin on gastric emptying in rats.

Authors:  Hiromi Endo; Hideo Yoshida; Yoshiro Kohno; Tetsuya Suga
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.